|EndoChoice Holdings Inc -- USA Stock|| |
USD 8.00 8.00 9,223,372,036,855%
Chairman of the Board
Mr. R. Scott Huennekens is Director of the company. Mr. Huennekens has served as President and Chief Executive Officer of Volcano Corporationrationration a medical imaging company since April 2002. Previously he served as the President and Chief Executive Officer of Digirad Corporationrationration a medical imaging company from 2000 to 2002. He originally joined Digirad as a startup in 1997 as Chief Operating Officer. From 1993 to 1997 he worked at Baxter International Inc. a global health care company with increasing responsibilities including as division Vice President of Sales and Marketing
Age: 50 Chairman Since 2016 MBA
Huennekens is a member of the board of directors of Volcano Corporationrationrationration, Sonendo, Scripps Translational Science Institute, Transenterix and the Medical Device Manufacturers Association . He received a B.Sc. in Business Administration from the University of Southern California and an MBA from Harvard Business School.
The company has Return on Asset (ROA)
of (0.47) %
which means that for every 100 dollars spent on asset it generated loss of $0.47. This is way below average.
The company reports 42.64 M of total liabilities with total debt to equity ratio (D/E) of 0.7 which is normal for its line of buisiness. EndoChoice Holdings Inc has Current Ratio of 5.52 indicating that it is in good position to pay out its debt commitments in time.
EndoChoice Holdings, Inc., a medical device company, designs and commercializes various solutions for gastrointestinal caregivers in the United States and internationally. EndoChoice Holdings Inc (GI) is traded on New York Stock Exchange in USA. It is located in GEORGIA, U.S.A and employs 501 people. EndoChoice Holdings is listed under Medical Equipment category by Fama And French industry classification.